-+ 0.00%
-+ 0.00%
-+ 0.00%

Calidi Biotherapeutics Q1 EPS $(0.43) Beats $(1.56) Estimate

Benzinga·05/14/2026 20:58:20
Listen to the news
Calidi Biotherapeutics (AMEX:CLDI) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(1.56) by 72.44 percent. This is a 80.09 percent increase over losses of $(2.16) per share from the same period last year.